mVisum STEMI Alert app

Last week San Antonio, Texas-based AirStrip Technologies filed a lawsuit in the Federal District Court of the Southern District of New York that alleges mVisum has infringed on AirStrip's patent for remote monitoring of patient medical data on smartphones. AirStrip announced that it had secured the patent at the end of August.

"AirStrip has a responsibility to exercise its patent protection in ways that rapidly drive the evolution of mHealth in a uniform and positive direction,” AirStrip CEO Alan Portela said in a prepared statement. “AirStrip respects the intellectual property of others, and will vigorously defend our own. Such action is not taken lightly, but we feel it is in the best interest of providers, our partners, and ultimately, patients.”

“AirStrip is committed to working in partnership with health systems, medical technology vendors and application developers to more quickly evolve mobility as the foundation for clinical transformation," AirStrip President and Chief Medical Officer Cameron Powell, MD, said in the prepared statement. "A more unified effort will ensure the evolution of best practices, reduce fragmentation, and drive the overall delivery of mobile applications that align with emerging standards. This will ultimately result in improved patient outcomes and better ensure patient safety.”

Like AirStrip, mVisum offers mobile applications that allows physicians to securely receive, view and respond to patient data recorded at the point of care right from their smartphones. One of mVisum offerings is its STEMI Alert System, which enables transmission of ECGs and other patient data directly to a physician’s smartphone to reduce the amount of time it takes for a diagnosis and to help lower door-to-balloon time. mVisum has inked key partnerships with companies that include Philips and Sprint. After months of demonstrating mVisum at industry events, Royal Philips Electronics formally announced an integration partnership with mVisum just last month. As of September mVisum's STEMI Alert smartphone app now integrates with Philips TraceMasterVue and IntelliSpace ECG management systems.

More in AirStrip's announcement below:

PRESS RELEASE: SAN ANTONIO -- AirStrip Technologies, Inc., a leader in healthcare mobility solutions delivering patient data to caregivers anytime, anywhere, has filed a lawsuit in Federal District Court for the Southern District of New York asserting that mVisum, Inc. is in violation of AirStrip’s patented intellectual property rights. The patent, which was issued on August 28, 2012, covers an industry-leading method for remote monitoring of patient medical data on smartphones such as the iPhone®, tablets such as the iPad, and on other mobile devices. This technology is key to more quickly evolving mobility as the foundation for clinical transformation.

"AirStrip has a responsibility to exercise its patent protection in ways that rapidly drive the evolution of mHealth in a uniform and positive direction,” AirStrip CEO Alan Portela stated. “AirStrip respects the intellectual property of others, and will vigorously defend our own. Such action is not taken lightly, but we feel it is in the best interest of providers, our partners, and ultimately, patients.”

AirStrip President and Chief Medical Officer Cameron Powell, MD, said, “AirStrip is committed to working in partnership with health systems, medical technology vendors and application developers to more quickly evolve mobility as the foundation for clinical transformation. A more unified effort will ensure the evolution of best practices, reduce fragmentation, and drive the overall delivery of mobile applications that align with emerging standards. This will ultimately result in improved patient outcomes and better ensure patient safety.”

About AirStrip Technologies, Inc.

Addressing the most pressing needs of a rapidly evolving global healthcare system, AirStrip develops mobile technology that drives enhanced clinician engagement, strengthened care coordination and improved clinical and financial performance. AirStrip’s platform has been tested and proven in the most rigorous care environments and it has received FDA 510(k) clearance. By unlocking, transforming and mobilizing live and historical patient information from existing monitoring devices and EHR systems to various mobile devices regardless of operating system, AirStrip helps transcend the geographic and technological barriers that delay informed clinician action. AirStrip’s enterprise-wide solution suite and its live and predictive analytics together create unprecedented opportunities to improve the health of individuals and populations. AirStrip is backed by investments from Sequoia Capital, Qualcomm, Inc., Hospital Corporation of America (HCA), and the Wellcome Trust. Visit www.airstriptech.com for more information.